181 related articles for article (PubMed ID: 19554542)
1. L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure.
Ytrebø LM; Kristiansen RG; Maehre H; Fuskevåg OM; Kalstad T; Revhaug A; Cobos MJ; Jalan R; Rose CF
Hepatology; 2009 Jul; 50(1):165-74. PubMed ID: 19554542
[TBL] [Abstract][Full Text] [Related]
2. L-Ornithine phenylacetate reduces ammonia in pigs with acute liver failure through phenylacetylglycine formation: a novel ammonia-lowering pathway.
Kristiansen RG; Rose CF; Fuskevåg OM; Mæhre H; Revhaug A; Jalan R; Ytrebø LM
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G1024-31. PubMed ID: 25258408
[TBL] [Abstract][Full Text] [Related]
3. L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats.
Davies NA; Wright G; Ytrebø LM; Stadlbauer V; Fuskevåg OM; Zwingmann C; Davies DC; Habtesion A; Hodges SJ; Jalan R
Hepatology; 2009 Jul; 50(1):155-64. PubMed ID: 19437490
[TBL] [Abstract][Full Text] [Related]
4. Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats.
Jover-Cobos M; Noiret L; Lee K; Sharma V; Habtesion A; Romero-Gomez M; Davies N; Jalan R
J Hepatol; 2014 Mar; 60(3):545-53. PubMed ID: 24512823
[TBL] [Abstract][Full Text] [Related]
5. Cerebral microdialysis reflects the neuroprotective effect of fractionated plasma separation and adsorption in acute liver failure better and earlier than intracranial pressure: a controlled study in pigs.
Prazak J; Laszikova E; Pantoflicek T; Ryska O; Koblihova E; Ryska M
BMC Gastroenterol; 2013 Jun; 13():98. PubMed ID: 23758689
[TBL] [Abstract][Full Text] [Related]
6. Extracellular brain ammonia levels in association with arterial ammonia, intracranial pressure and the use of albumin dialysis devices in pigs with acute liver failure.
Zwirner K; Thiel C; Thiel K; Morgalla MH; Königsrainer A; Schenk M
Metab Brain Dis; 2010 Dec; 25(4):407-12. PubMed ID: 21086032
[TBL] [Abstract][Full Text] [Related]
7. Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia.
Stravitz RT; Gottfried M; Durkalski V; Fontana RJ; Hanje AJ; Koch D; Hameed B; Ganger D; Subramanian RM; Bukofzer S; Ravis WR; Clasen K; Sherker A; Little L; Lee WM;
Hepatology; 2018 Mar; 67(3):1003-1013. PubMed ID: 29080224
[TBL] [Abstract][Full Text] [Related]
8. Ornithine phenylacetate revisited.
Jover-Cobos M; Noiret L; Sharifi Y; Jalan R
Metab Brain Dis; 2013 Jun; 28(2):327-31. PubMed ID: 23456516
[TBL] [Abstract][Full Text] [Related]
9. Interorgan metabolism of ornithine phenylacetate (OP)--a novel strategy for treatment of hyperammonemia.
Dadsetan S; Sørensen M; Bak LK; Vilstrup H; Ott P; Schousboe A; Jalan R; Keiding S; Waagepetersen HS
Biochem Pharmacol; 2013 Jan; 85(1):115-23. PubMed ID: 23103564
[TBL] [Abstract][Full Text] [Related]
10. Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure.
Rose C; Ytrebø LM; Davies NA; Sen S; Nedredal GI; Belanger M; Revhaug A; Jalan R
Hepatology; 2007 Dec; 46(6):1883-92. PubMed ID: 17705298
[TBL] [Abstract][Full Text] [Related]
11. L-ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure.
Rose C; Michalak A; Rao KV; Quack G; Kircheis G; Butterworth RF
Hepatology; 1999 Sep; 30(3):636-40. PubMed ID: 10462368
[TBL] [Abstract][Full Text] [Related]
12. Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure.
Kristiansen RG
Metab Brain Dis; 2016 Dec; 31(6):1357-1358. PubMed ID: 27651377
[TBL] [Abstract][Full Text] [Related]
13. L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.
Jalan R; Wright G; Davies NA; Hodges SJ
Med Hypotheses; 2007; 69(5):1064-9. PubMed ID: 17467190
[TBL] [Abstract][Full Text] [Related]
14. Ammonia reduction with ornithine phenylacetate restores brain eNOS activity via the DDAH-ADMA pathway in bile duct-ligated cirrhotic rats.
Balasubramaniyan V; Wright G; Sharma V; Davies NA; Sharifi Y; Habtesion A; Mookerjee RP; Jalan R
Am J Physiol Gastrointest Liver Physiol; 2012 Jan; 302(1):G145-52. PubMed ID: 21903766
[TBL] [Abstract][Full Text] [Related]
15. Ornithine phenylacetate prevents disturbances of motor-evoked potentials induced by intestinal blood in rats with portacaval anastomosis.
Oria M; Romero-Giménez J; Arranz JA; Riudor E; Raguer N; Córdoba J
J Hepatol; 2012 Jan; 56(1):109-14. PubMed ID: 21835138
[TBL] [Abstract][Full Text] [Related]
16. Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study.
Sen S; Rose C; Ytrebø LM; Davies NA; Nedredal GI; Drevland SS; Kjønnø M; Prinzen FW; Hodges SJ; Deutz NE; Williams R; Butterworth RF; Revhaug A; Jalan R
Crit Care Med; 2006 Jan; 34(1):158-64. PubMed ID: 16374170
[TBL] [Abstract][Full Text] [Related]
17. Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure.
Tofteng F; Hauerberg J; Hansen BA; Pedersen CB; Jørgensen L; Larsen FS
J Cereb Blood Flow Metab; 2006 Jan; 26(1):21-7. PubMed ID: 15959460
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow.
Jalan R; Olde Damink SW; Hayes PC; Deutz NE; Lee A
J Hepatol; 2004 Oct; 41(4):613-20. PubMed ID: 15464242
[TBL] [Abstract][Full Text] [Related]
19. Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure.
Rose C; Michalak A; Pannunzio M; Chatauret N; Rambaldi A; Butterworth RF
Hepatology; 2000 Apr; 31(4):872-7. PubMed ID: 10733542
[TBL] [Abstract][Full Text] [Related]
20. Safety of ornithine phenylacetate in cirrhotic decompensated patients: an open-label, dose-escalating, single-cohort study.
Ventura-Cots M; Arranz JA; Simón-Talero M; Torrens M; Blanco A; Riudor E; Fuentes I; Suñé P; Soriano G; Córdoba J
J Clin Gastroenterol; 2013; 47(10):881-7. PubMed ID: 23751856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
